MYC and neoplasm: It should be noted that loss of SK-2 had slight protective effects against c-Myc degradation and tumour suppression (∼20–30%) in SK-2−/− MEFs or SK-2−/− k/o mice, respectively, compared to controls (Fig 5C–E).